Back to search
Papillary Microcarcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Papillary Microcarcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Papillary Microcarcinoma trials you may qualify forThe purpose of this study is to better understand the outcomes of active surveillance (observation) instead of immediate surgery, which is the current standard…
The study is being done to answer the following question: What are the specific clinical and molecular features that will help us predict which small thyroid ca…
In 2016, there were 203,000 new cases of thyroid cancer in China, ranking 7th among all malignant tumours and 4th among women, and showing a rapid growth trend.…
Thyroid surgery has always been the mainstay of treatment for thyroid cancer. Thyroid surgery carries a low risk of complications that include recurrent or supe…
This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Th…
Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove t…
Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid mi…
This is a prospective, observational, multi-center study examining the long-term outcomes of patients with small, low risk papillary thyroid cancer who offered…